Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News HLS Therapeutics Inc T.HLS

Alternate Symbol(s):  HLTRF

Healthcare Industrials Auto Parts Diversified Industrials
HLS Therapeutics Inc. is a pharmaceutical company. It is focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the... see more

Recent & Breaking News (TSX:HLS)

HLS Therapeutics Announces Q1 Fiscal 2022 Financial Results

Canada NewsWire May 5, 2022

HLS Therapeutics to Host Q1 Fiscal 2022 Financial Results Conference Call

Canada NewsWire April 28, 2022

HLS Therapeutics completes negotiations with pCPA for Vascepa®

Canada NewsWire April 26, 2022

HLS Therapeutics to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference

Canada NewsWire April 25, 2022

HLS Therapeutics Announces Q4 and Fiscal 2021 Financial Results

Canada NewsWire March 17, 2022

HLS Therapeutics to Host Q4 & Fiscal 2021 Financial Results Conference Call

Canada NewsWire March 14, 2022

HLS Therapeutics to Present at the Sidoti Investor Conference

PR Newswire January 12, 2022

HLS Therapeutics Establishes Automatic Share Purchase Plan

PR Newswire December 20, 2021

HLS Therapeutics to Present at Stifel GMP's Future of Healthcare Conference

PR Newswire December 1, 2021

HLS Therapeutics to Present at the Stifel 2021 Virtual Healthcare Conference

PR Newswire November 11, 2021

HLS Therapeutics Announces Q3 Fiscal 2021 Financial Results

PR Newswire November 4, 2021

HLS Therapeutics to Host Q3 2021 Financial Results Conference Call

PR Newswire October 21, 2021

HLS Therapeutics to Participate in Two Virtual Non-Deal Roadshows

PR Newswire October 4, 2021

HLS Therapeutics Announces Promotional Agreement with Pfizer for Vascepa® in Canada

PR Newswire August 16, 2021

HLS Therapeutics Announces Second Quarter Fiscal 2021 Financial Results

PR Newswire August 5, 2021

HLS Therapeutics to Present at the Canaccord Genuity 41st Annual Growth Conference

PR Newswire August 4, 2021

HLS Therapeutics to Host Q2 2021 Financial Results Conference Call

PR Newswire July 22, 2021

HLS Therapeutics Reports Annual Meeting Results

Canada NewsWire June 18, 2021

HLS Therapeutics to Participate in Virtual Non-Deal Roadshow on June 16, 2021

Canada NewsWire June 15, 2021

HLS Therapeutics to Participate in Virtual Non-Deal Roadshow on June 10, 2021

Canada NewsWire June 9, 2021